Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.

Argani P, Hicks J, De Marzo AM, Albadine R, Illei PB, Ladanyi M, Reuter VE, Netto GJ.

Am J Surg Pathol. 2010 Sep;34(9):1295-303. doi: 10.1097/PAS.0b013e3181e8ce5b.

2.

t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases.

Smith NE, Illei PB, Allaf M, Gonzalez N, Morris K, Hicks J, Demarzo A, Reuter VE, Amin MB, Epstein JI, Netto GJ, Argani P.

Am J Surg Pathol. 2014 May;38(5):604-14. doi: 10.1097/PAS.0000000000000203.

3.

Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.

Martignoni G, Gobbo S, Camparo P, Brunelli M, Munari E, Segala D, Pea M, Bonetti F, Illei PB, Netto GJ, Ladanyi M, Chilosi M, Argani P.

Mod Pathol. 2011 Oct;24(10):1313-9. doi: 10.1038/modpathol.2011.93. Epub 2011 May 20.

4.

TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.

Rao Q, Williamson SR, Zhang S, Eble JN, Grignon DJ, Wang M, Zhou XJ, Huang W, Tan PH, Maclennan GT, Cheng L.

Am J Surg Pathol. 2013 Jun;37(6):804-15. doi: 10.1097/PAS.0b013e31827e17cb.

PMID:
23598965
5.

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

Green WM, Yonescu R, Morsberger L, Morris K, Netto GJ, Epstein JI, Illei PB, Allaf M, Ladanyi M, Griffin CA, Argani P.

Am J Surg Pathol. 2013 Aug;37(8):1150-63. doi: 10.1097/PAS.0b013e31828a69ae.

PMID:
23715164
6.

[Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].

Rao Q, Zhou J, Zhang RS, Ma HH, Zhou HB, Lu ZF, Zhou XJ.

Zhonghua Bing Li Xue Za Zhi. 2010 Sep;39(9):582-6. Chinese.

PMID:
21092583
7.

Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3.

Xia QY, Wang XT, Zhan XM, Tan X, Chen H, Liu Y, Shi SS, Wang X, Wei X, Ye SB, Li R, Ma HH, Lu ZF, Zhou XJ, Rao Q.

Am J Surg Pathol. 2017 May;41(5):663-676. doi: 10.1097/PAS.0000000000000837.

PMID:
28288037
8.

Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.

Argani P, Olgac S, Tickoo SK, Goldfischer M, Moch H, Chan DY, Eble JN, Bonsib SM, Jimeno M, Lloreta J, Billis A, Hicks J, De Marzo AM, Reuter VE, Ladanyi M.

Am J Surg Pathol. 2007 Aug;31(8):1149-60.

PMID:
17667536
9.

TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.

Xu Y, Rao Q, Xia Q, Shi S, Shi Q, Ma H, Lu Z, Chen H, Zhou X.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):2690-9. eCollection 2015.

10.

Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.

Martignoni G, Pea M, Gobbo S, Brunelli M, Bonetti F, Segala D, Pan CC, Netto G, Doglioni C, Hes O, Argani P, Chilosi M.

Mod Pathol. 2009 Aug;22(8):1016-22. doi: 10.1038/modpathol.2009.58. Epub 2009 Apr 24.

11.

Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.

Pradhan D, Roy S, Quiroga-Garza G, Cieply K, Mahaffey AL, Bastacky S, Dhir R, Parwani AV.

Diagn Pathol. 2015 Sep 29;10:179. doi: 10.1186/s13000-015-0412-z.

12.

MiT family translocation renal cell carcinoma.

Argani P.

Semin Diagn Pathol. 2015 Mar;32(2):103-13. doi: 10.1053/j.semdp.2015.02.003. Epub 2015 Feb 4. Review.

PMID:
25758327
13.

Pseudocapsule of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a clue for tumor enucleation?

Cheng X, He J, Gan W, Fan X, Yang J, Zhu B, Guo H.

Int J Clin Exp Pathol. 2015 May 1;8(5):5403-10. eCollection 2015.

14.

Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.

Hayes M, Peckova K, Martinek P, Hora M, Kalusova K, Straka L, Daum O, Kokoskova B, Rotterova P, PivovarĨikova K, Branzovsky J, Dubova M, Vesela P, Michal M, Hes O.

Virchows Arch. 2015 Mar;466(3):313-22. doi: 10.1007/s00428-014-1702-7. Epub 2014 Dec 28.

PMID:
25544614
15.

Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.

Klatte T, Streubel B, Wrba F, Remzi M, Krammer B, de Martino M, Waldert M, Marberger M, Susani M, Haitel A.

Am J Clin Pathol. 2012 May;137(5):761-8. doi: 10.1309/AJCPQ6LLFMC4OXGC.

PMID:
22523215
16.

Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network.

Malouf GG, Camparo P, Oudard S, Schleiermacher G, Theodore C, Rustine A, Dutcher J, Billemont B, Rixe O, Bompas E, Guillot A, Boccon-Gibod L, Couturier J, MoliniƩ V, Escudier B.

Ann Oncol. 2010 Sep;21(9):1834-8. doi: 10.1093/annonc/mdq029. Epub 2010 Feb 12.

PMID:
20154303
17.

A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma.

Kurisaki-Arakawa A, Saito T, Takahashi M, Mitani K, Fukumura Y, Nagashima Y, Argani P, Yao T.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2585-90. eCollection 2013.

18.
19.

Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.

Altinok G, Kattar MM, Mohamed A, Poulik J, Grignon D, Rabah R.

Pediatr Dev Pathol. 2005 Mar-Apr;8(2):168-80. Epub 2005 Mar 8.

PMID:
15747097
20.

PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.

Rao Q, Shen Q, Xia QY, Wang ZY, Liu B, Shi SS, Shi QL, Yin HL, Wu B, Ye SB, Li L, Chen JY, Pan MH, Li Q, Li R, Wang X, Zhang RS, Yu B, Ma HH, Lu ZF, Zhou XJ.

Am J Surg Pathol. 2015 Sep;39(9):1181-96. doi: 10.1097/PAS.0000000000000502.

PMID:
26274027

Supplemental Content

Support Center